Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/136274
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | de Bock, Martin | en_US |
dc.contributor.author | Agwu, Juliana Chizo | en_US |
dc.contributor.author | Deabreu, Matt | en_US |
dc.contributor.author | Dovc, Klemen | en_US |
dc.contributor.author | Maahs, David M. | en_US |
dc.contributor.author | Marcovecchio, M. Loredana | en_US |
dc.contributor.author | Mahmud, Farid H. | en_US |
dc.contributor.author | Novoa Medina, Yeray | en_US |
dc.contributor.author | Priyambada, Leena | en_US |
dc.contributor.author | Smart, Carmel E. | en_US |
dc.contributor.author | Dimeglio, Linda A. | en_US |
dc.date.accessioned | 2025-02-17T16:12:02Z | - |
dc.date.available | 2025-02-17T16:12:02Z | - |
dc.date.issued | 2024 | en_US |
dc.identifier.issn | 1663-2818 | en_US |
dc.identifier.other | WoS | - |
dc.identifier.uri | http://hdl.handle.net/10553/136274 | - |
dc.description.abstract | The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of <= 6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is <= 7.0% (53 mmol/mol). | en_US |
dc.language | spa | en_US |
dc.relation.ispartof | Hormone Research In Paediatrics | en_US |
dc.source | Hormone Research In Paediatrics[ISSN 1663-2818],v. 97 (6), p. 546-554, (Diciembre 2024) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320502 Endocrinología | en_US |
dc.subject.other | Risk-Factors | en_US |
dc.subject.other | Tight-Range | en_US |
dc.subject.other | Type-1 | en_US |
dc.subject.other | Management | en_US |
dc.subject.other | Children | en_US |
dc.subject.other | Time | en_US |
dc.subject.other | Retinopathy | en_US |
dc.subject.other | Hba(1C) | en_US |
dc.subject.other | Obesity | en_US |
dc.subject.other | Glycemic Targets | en_US |
dc.subject.other | Technology | en_US |
dc.subject.other | Burden | en_US |
dc.subject.other | Diabetes-Related Complications | en_US |
dc.title | International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1159/000543266 | en_US |
dc.identifier.isi | 001415460300001 | - |
dc.identifier.eissn | 1663-2826 | - |
dc.description.lastpage | 554 | en_US |
dc.identifier.issue | 6 | - |
dc.description.firstpage | 546 | en_US |
dc.relation.volume | 97 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.description.numberofpages | 9 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:de Bock, M | - |
dc.contributor.wosstandard | WOS:Agwu, JC | - |
dc.contributor.wosstandard | WOS:Deabreu, M | - |
dc.contributor.wosstandard | WOS:Dovc, K | - |
dc.contributor.wosstandard | WOS:Maahs, DM | - |
dc.contributor.wosstandard | WOS:Marcovecchio, ML | - |
dc.contributor.wosstandard | WOS:Mahmud, FH | - |
dc.contributor.wosstandard | WOS:Nóvoa-Medina, Y | - |
dc.contributor.wosstandard | WOS:Priyambada, L | - |
dc.contributor.wosstandard | WOS:Smart, CE | - |
dc.contributor.wosstandard | WOS:Dimeglio, LA | - |
dc.date.coverdate | Diciembre 2024 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
item.fulltext | Con texto completo | - |
item.grantfulltext | open | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Novoa Medina, Yeray | - |
Colección: | Artículos |
Citas de WEB OF SCIENCETM
Citations
2
actualizado el 30-mar-2025
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.